mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.2 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.2 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |